This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| CEA NeuroSpin | |
|---|---|
| Name | NeuroSpin |
| Established | 1996 |
| Location | Saclay, Île-de-France, France |
| Type | Research center |
| Parent | Commissariat à l'Énergie Atomique et aux Énergies Alternatives |
CEA NeuroSpin is a high-field neuroimaging research center operated by the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. It focuses on the development and application of magnetic resonance imaging technologies for human brain research, cognitive neuroscience, psychiatric disorders, and neurology. The center links advanced engineering, computational modeling, and clinical collaboration to support translational science.
NeuroSpin operates at the intersection of hardware engineering, neuroscience, and clinical translation, engaging with institutions such as Université Paris-Saclay, INSERM, CNRS, Hôpital Pitié-Salpêtrière, Institut du Cerveau and international facilities like Max Planck Society, National Institutes of Health, Wellcome Trust, European Molecular Biology Laboratory and Karolinska Institutet. Scientific themes at the site include high-field magnet design, neuroanatomy mapping, functional imaging, and connectomics, drawing users from École Polytechnique, Université Paris Descartes, Imperial College London, Massachusetts Institute of Technology, Harvard University, University College London, Columbia University, University of Oxford, ETH Zurich, Technical University of Munich, Duke University, Stanford University, University of California, Berkeley, Johns Hopkins University, McGill University, University of Toronto, Monash University, University of Melbourne, Peking University, Tsinghua University, Seoul National University, University of Tokyo, RIKEN, Swiss Federal Institute of Technology Lausanne, Ludwig Maximilian University of Munich, University of Cambridge, Yale University, Princeton University, University of Chicago, Northwestern University, Carnegie Mellon University.
NeuroSpin was created within the framework of national and European initiatives involving entities like Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Direction générale de la recherche et de l'innovation, building on earlier projects supported by European Research Council, Agence nationale de la recherche, Fondation de France and collaborations with corporations such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Bruker Corporation. Early milestones reflect influences from pioneers and institutions including Jean-Pierre Changeux, André Holveck, Institut Pasteur, Collège de France, L'Hôpital Sainte-Anne, Centre Hospitalier Universitaire de Toulouse, Hôpitaux Universitaires de Strasbourg, INSERM Unit 1000, CNRS UMR, and networks like Human Brain Project, Brain/MINDS, ENIGMA Consortium and International Consortium for Brain Mapping.
The site houses ultra-high field magnets and ancillary facilities linked to industrial partners and academic nodes including CEA Saclay, Plateau de Saclay, Commissariat à l'Energie Atomique, Centre National d'Études Spatiales, CEA List, CEA LETI, Genopole, Institut Gustave Roussy, Hôpital Antoine Béclère, AP-HP, and regional campuses like Orsay and Gif-sur-Yvette. Infrastructure includes cryogenic systems, magnet shims, RF coil workshops, high-performance computing clusters interoperable with PRACE, XSEDE, Compute Canada, EuroHPC, and data repositories aligned with European Open Science Cloud and standards such as those promoted by FAIR principles participants including ELIXIR and INCF.
Research spans functional magnetic resonance imaging, structural imaging, diffusion MRI, spectroscopy, real-time neurofeedback, and multimodal integration with modalities from collaborators like Magnetoencephalography groups at Institut Pasteur and University of Cambridge, and invasive electrophysiology centers at INSERM and CNRS laboratories. Projects align with international consortia such as Human Connectome Project, ADNI, UK Biobank, ABIDE, ENIGMA, Brain Tumor Segmentation Challenge, OpenfMRI and disease-oriented networks addressing Alzheimer's disease, Parkinson's disease, Schizophrenia, Major depressive disorder, Autism spectrum disorder, Epilepsy and Stroke. Translational efforts link to clinical trials run with Institut Curie, Hôpital Européen Georges-Pompidou, Institut Pasteur de Lille and pharmaceutical partners like Sanofi, Roche, Novartis.
NeuroSpin hosts ultra-high-field MRI systems including 3T, 7T and experimental 11.7T platforms developed with Siemens Healthineers and research manufacturers such as Bruker. Instrumentation includes specialized RF coils, gradient systems, cryogenic receivers, and bespoke head coils influenced by engineering groups at CEA-Leti, Thomson-CSF heritage, and techniques originating from laboratories like Laboratoire Kastler Brossel, NeuroSpin's collaboration units, and methods co-developed with academic engineers from École Normale Supérieure, INRIA, LORIA, CNRS UMR 7225, and Laboratoire de Physique des Solides. Computational pipelines utilize software from communities including FSL, SPM, AFNI, FreeSurfer, MRtrix, dcm2niix, NiPy, BIDS ecosystem tools, and machine learning frameworks from TensorFlow, PyTorch and high-performance toolchains connected to NVIDIA hardware.
NeuroSpin maintains partnerships with universities, hospitals, industry, and consortia: Université Paris-Saclay, INSERM, CNRS, AP-HP, Institut Pasteur, CEA, Siemens Healthineers, GE Healthcare, Philips, Bruker, European Commission research programs, European Research Council, Wellcome Trust, NIH, HBP, Human Brain Project, ENIGMA Consortium, Human Connectome Project, UK Biobank, ELIXIR, INCF, Max Planck Society, Karolinska Institutet, Massachusetts General Hospital, McGill University, and regional innovation clusters like Plateau de Saclay and Genopole.
NeuroSpin has contributed to high-resolution brain atlases, methodological advances in ultra-high-field MRI, and datasets used by projects such as Human Connectome Project and ENIGMA. Its developments influence clinical protocols at institutions like Hôpital Pitié-Salpêtrière and research directions at Institut du Cerveau and have informed policy discussions within European Commission research frameworks, funding agencies such as Agence nationale de la recherche and philanthropic funders including Wellcome Trust and Fondation pour la Recherche Médicale. Technologies and protocols from the center have been cited across collaborations with Siemens Healthineers, Bruker, Philips, and academic partners at Harvard Medical School, University College London, Université de Montréal, Imperial College London, Johns Hopkins University, Stanford University and others.
Category:Research institutes in France